CAGRI — Cagrilintide Peptide 5mg & 10mg

In stock and ready to ship. Buy CAGRI — Cagrilintide Peptide 5mg & 10mg online from MyGLP1Store — third-party tested, with a certificate of analysis available on request. Order by 4:00 PM ET Monday–Friday or 12:00 PM ET Saturday and it ships the same day with tracking.

• Ships same day. Order by 4 PM ET Mon–Fri or 12 PM ET Sat. Choose Ground, 2-Day or Next Day at checkout.
• Tested. Certificate of analysis available on request.
• Earn rewards — registered customers get loyalty points on every order.

Cagrilintide for Sale — Research-Grade, Third-Party Tested

Looking to buy Cagrilintide? MyGLP1Store offers Cagrilintide for sale as a third-party lab-tested research peptide sourced direct from the manufacturer, with purity documented per lot and same-day U.S. shipping. Veteran-owned and trusted by researchers (Trustpilot 4.8).

Cagrilintide (CAGRI) – 5mg & 10mg Lyophilized Research Peptide

Cagrilintide (research code AM833), listed in research catalogs as CAGRI, is a long-acting amylin analog studied in metabolic research models for its role in appetite regulation, satiety signaling, and energy balance. Amylin is a peptide hormone co-secreted with insulin; long-acting analogs such as cagrilintide are widely investigated in obesity and metabolic research, frequently alongside GLP-1 receptor agonists.

What Is Cagrilintide Used for in Research?

In laboratory settings, Cagrilintide (CAGRI) is explored for amylin-receptor signaling, food-intake regulation, post-meal glucose response, and combination models. One of the most studied combinations pairs Cagrilintide with Semaglutide — together referred to as CagriSema — to investigate complementary appetite and metabolic pathways. For a deeper overview of how amylin analogs are studied alongside incretin compounds, see our guide to GLP-1 research peptides.

Product Details

• Peptide: Cagrilintide (CAGRI / AM833)
• Purity: See Certificate of Analysis
• Form: Lyophilized powder
• Quantity: 5mg or 10mg per vial
• Storage: Store at -20°C. After reconstitution, refrigerate at 2–8°C and use within 30 days. See how to reconstitute GLP-1 peptides for the step-by-step method.

Research Applications

• Amylin receptor pathway studies
• Appetite and satiety signaling research
• Glucose regulation and post-meal response models
• Energy balance and metabolic function investigations
• Combination research with GLP-1 receptor agonists (e.g., CagriSema)

Why Buy Cagrilintide From MyGLP1Store

Our CAGRI is third-party lab tested with documented purity and comes direct from the manufacturer. MyGLP1Store is a veteran-owned, U.S.-based supplier offering same-day domestic shipping and a verified Trustpilot rating of 4.8 — a trusted source for researchers looking to buy Cagrilintide research peptide in the United States.

Cagrilintide (CAGRI) — Frequently Asked Questions

What is the cagri peptide?

“Cagri” is the research shorthand for Cagrilintide (AM833), a long-acting amylin analog peptide studied in appetite-regulation and metabolic research models. It is supplied here as a 5mg or 10mg lyophilized research vial.

How does cagrilintide differ from tirzepatide in research?

They act on different receptor systems: cagrilintide is an amylin-receptor analog, while tirzepatide is a dual GIP/GLP-1 receptor agonist. In published research they are studied for complementary — not interchangeable — metabolic signaling pathways.

What is CagriSema?

CagriSema is the studied combination of cagrilintide with semaglutide. We supply it as a Cagrilintide + Semaglutide blend for combination-pathway research models.

Is your cagrilintide third-party tested?

Yes — every batch is tested by an independent third-party laboratory for purity and identity before it is released.

Where can I buy cagrilintide?

You can buy cagrilintide directly from MyGLP1Store in 5mg and 10mg research vials with same-day US shipping.

Certificate of Analysis (COA)

Every cagrilintide batch is tested by an independent third-party laboratory for identity and purity before release — we publish the documentation rather than just claiming it. View the latest Cagrilintide COA, or request the certificate for your specific lot after purchase.

Research References

1. Lau DCW, et al. Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled, dose-finding phase 2 trial. Lancet. 2021;398(10317):2160–2170. PubMed
2. Enebo LB, et al. Concomitant cagrilintide and semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial. Lancet. 2021;397(10286):1736–1748. PubMed

Nothing here is medical advice or a dosing recommendation.

---

Related Research Compounds

The Cagrilintide peptide is frequently studied alongside other incretin and amylin research compounds. Explore related third-party tested lyophilized peptides:

• Buy Retatrutide (RETA) — triple GIP/GLP-1/glucagon receptor agonist.
• Semaglutide (SEMA) — GLP-1 receptor agonist research peptide.
• Tirzepatide (TIRZ) — dual GIP/GLP-1 agonist.
• Cagrilintide + Semaglutide blend — dual-peptide metabolic research combination.

---

Cagrilintide — Further Research Reading

Background methodology and comparative data from our research library:

• Semaglutide research guide — the GLP-1 agonist most often paired with cagrilintide in combination models.
• Semaglutide vs tirzepatide — dose comparison across the incretin research class.
• Retatrutide research guide — triple-agonist mechanism and published trial data.
• Quality standards in GLP-1 research — how laboratories evaluate purity and analytical documentation.
• About our research lead — who reviews the analytical data behind every lot.

{“@context”:”https://schema.org”,”@type”:”FAQPage”,”mainEntity”:[{“@type”:”Question”,”name”:”What is the cagri peptide?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”Cagri is the research shorthand for Cagrilintide (AM833), a long-acting amylin analog peptide studied in appetite-regulation and metabolic research models. It is supplied as a 5mg or 10mg lyophilized research vial.”}},{“@type”:”Question”,”name”:”How does cagrilintide differ from tirzepatide in research?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”They act on different receptor systems: cagrilintide is an amylin-receptor analog, while tirzepatide is a dual GIP/GLP-1 receptor agonist. In published research they are studied for complementary – not interchangeable – metabolic signaling pathways.”}},{“@type”:”Question”,”name”:”What is CagriSema?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”CagriSema is the studied combination of cagrilintide with semaglutide. MyGLP1Store supplies it as a Cagrilintide + Semaglutide blend for combination-pathway research models.”}},{“@type”:”Question”,”name”:”Is your cagrilintide third-party tested?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”Yes – every batch is tested by an independent third-party laboratory for purity and identity before it is released.”}},{“@type”:”Question”,”name”:”Where can I buy cagrilintide?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”You can buy cagrilintide directly from MyGLP1Store in 5mg and 10mg research vials with same-day US shipping.”}}]}

For research use only.